.
Science Daily : Hormone Disorders
Hormone Disorders News -- ScienceDaily
Read the latest research on endocrinology. Learn about hormone disorders, new hormone treatment options, hormone therapy and more.

Hormone Disorders News -- ScienceDaily
  • Postmenopausal hormone therapy exceeding ten years may protect from dementia
    Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study. The study explored the association between postmenopausal hormone replacement therapy, Alzheimer's disease, dementia and cognition in two nation-wide case-control studies and two longitudinal cohort studies. The largest study comprised approximately 230,000 Finnish women and the follow-up time in different studies was up to 20 years.

  • Keeping up the pressure
    Besides the classic stress response – an acute reaction that gradually abates when the threat passes – our bodies appear to have a separate mechanism that deals only with chronic stress, research indicates. These findings may lead to better diagnosis of and treatment for anxiety and depression.

  • 'Anti-aging' hormone could unlock new treatments for kidney and heart disease
    A new study has found that patients with diabetes suffering from the early stages of kidney disease have a deficiency of the protective 'anti-aging' hormone, Klotho.

  • Hair analysis may help diagnose Cushing syndrome, researchers report
    Analyzing a hair sample may help with the diagnosis of Cushing syndrome, a rare and potentially fatal disorder in which the body overproduces the stress hormone cortisol, according to researchers.

  • Prenatal bisphenol A exposure weakens body's fullness cues
    An expectant mother's exposure to the endocrine-disrupting chemical bisphenol A (BPA) can raise her offspring's risk of obesity by reducing sensitivity to a hormone responsible for controlling appetite, according to a mouse study.

The Canary Club is an educational advisory group with a team of medical advisors headed by Richard Shames, M.D.